These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38765726)

  • 1. Treatment Response to Diphenylcyclopropenone in Patients with Alopecia Totalis/Universalis.
    Varghese SA; Nair SS; George AE; Yadev I
    Int J Trichology; 2023; 15(4):149-153. PubMed ID: 38765726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis.
    Lee S; Kim BJ; Lee YB; Lee WS
    JAMA Dermatol; 2018 Oct; 154(10):1145-1151. PubMed ID: 30073292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series.
    Durdu M; Özcan D; Baba M; Seçkin D
    J Am Acad Dermatol; 2015 Apr; 72(4):640-50. PubMed ID: 25653027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of anthralin in combination with diphenylcyclopropenone in the treatment of alopecia areata: a retrospective case series.
    Nasimi M; Ghandi N; Abedini R; Mirshamsi A; Shakoei S; Seirafi H
    Arch Dermatol Res; 2019 Oct; 311(8):607-613. PubMed ID: 31165933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Efficacy of Diphenylcyclopropenone in Alopecia Areata: Retrospective Data Analysis of 50 Patients.
    Chiang KS; Mesinkovska NA; Piliang MP; Bergfeld WF
    J Investig Dermatol Symp Proc; 2015 Nov; 17(2):50-5. PubMed ID: 26551948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical immunomodulation with diphenylcyclopropenone for alopecia areata: the Lebanese experience.
    El Khoury J; Abd-el-Baki J; Succariah F; Abbas O; Kibbi AG; Kurban M
    Int J Dermatol; 2013 Dec; 52(12):1551-6. PubMed ID: 24134785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Excellent Response to Tofacitinib in a Pediatric Alopecia Patient: A Case Report and Review.
    Brown L; Skopit S
    J Drugs Dermatol; 2018 Aug; 17(8):914-917. PubMed ID: 30124734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population.
    Aghaei S
    BMC Dermatol; 2005 May; 5():6. PubMed ID: 15918897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of diphenylcyclopropenone in alopecia areata: a comparison of two treatment regimens.
    Nowicka D; Maj J; Jankowska-Konsur A; Hryncewicz-Gwóźdź A
    Postepy Dermatol Alergol; 2018 Dec; 35(6):577-581. PubMed ID: 30618524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis.
    Sharath S; Sardana K; Khurana A
    Indian Dermatol Online J; 2024; 15(1):49-54. PubMed ID: 38282998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata.
    Ghandi N; Daneshmand R; Hatami P; Abedini R; Nasimi M; Aryanian Z; Vance TM
    Int Immunopharmacol; 2021 Oct; 99():107971. PubMed ID: 34298402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of treatment efficacy of diphenylcyclopropenone (DPCP) for alopecia areata.
    Kutlubay Z; Sevim A; Aydın Ö; Vehid S; Serdaroğlu S
    Turk J Med Sci; 2020 Dec; 50(8):1817-1824. PubMed ID: 31655499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term follow-up of the efficacy of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia areata totalis or universalis].
    Chartaux E; Joly P
    Ann Dermatol Venereol; 2010; 137(8-9):507-13. PubMed ID: 20804893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical diphenylcyclopropenone plus topical 0.5% anthralin versus topical diphenylcyclopropenone alone for the treatment of chronic extensive alopecia areata: A split-scalp, double-blind, controlled study.
    Thuangtong R; Suvansuthi S; Maneeprasopchoke P; Sukakul T; Techakajornkeart R; Chaweekulrat P; Wongdama S; Triwongwaranat D
    Int J Trichology; 2022; 14(3):91-96. PubMed ID: 35755959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical immunotherapy in combination with anthralin in the treatment of refractory alopecia areata.
    Kagami S; Kishi Y; Hino H
    J Cosmet Dermatol; 2020 Sep; 19(9):2411-2414. PubMed ID: 32621407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata.
    Sotiriadis D; Patsatsi A; Lazaridou E; Kastanis A; Vakirlis E; Chrysomallis F
    Clin Exp Dermatol; 2007 Jan; 32(1):48-51. PubMed ID: 17004987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A Promising Therapy for the Treatment of Alopecia Areata: A Case Report of Six Patients.
    Shivanna CB; Shenoy C; Priya RA
    Int J Trichology; 2018; 10(3):103-107. PubMed ID: 30034188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Methotrexate Alone vs Methotrexate Plus Low-Dose Prednisone in Patients With Alopecia Areata Totalis or Universalis: A 2-Step Double-Blind Randomized Clinical Trial.
    Joly P; Lafon A; Houivet E; Donnadieu N; Richard MA; Dupuy A; Delaporte E; Bernard P; Machet L; Tosti A; Del Marmol V; Grimalt R; de Viragh PA; Benichou J; Chosidow O; Assouly P; Reygagne P
    JAMA Dermatol; 2023 Apr; 159(4):403-410. PubMed ID: 36884234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective comparative study of two regimens of diphenylcyclopropenone (DPCP) in the treatment of alopecia areata.
    Al Bazzal A; Hatami P; Abedini R; Etesami I; Ayanian Z; Ghandi N
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108186. PubMed ID: 34710658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of tofacitinib in treatment of alopecia universalis in two patients.
    Gupta AK; Carviel JL; Abramovits W
    J Eur Acad Dermatol Venereol; 2016 Aug; 30(8):1373-8. PubMed ID: 27306107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.